Histology of intestinal allografts: Lymphocyte apoptosis and phagocytosis of lymphocytic apoptotic bodies are diagnostic findings of acute rejection in addition to crypt apoptosis

American Journal of Surgical Pathology

Volumn 37, Issue 2, 2013, Pages 178-184

  Tsuruyama, Tatsuaki ^a   Okamoto, Shinya ^b   Fujimoto, Yasuhiro ^b   Yoshizawa, Atsushi ^b   Yoshitoshi, Elena ^b   Egawa, Hiroto ^c   Nakase, Hiroshi ^d   Aini, Wulamujiang ^a   Miyao, Masashi ^a   Tamaki, Keiji ^a   Yamabe, Hirohiko ^a   Haga, Hironori ^a   Uemoto, Shinji ^b  

^a KYOTO UNIVERSITY   (Japan)

^b Departments of Hepato pancreato biliary Surgery and Transplantation   (Japan)

^c TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

acute cellular rejection; apoptosis; Fas ligand; intestinal transplantation; lymphocyte; phagocytosis

Indexed keywords

BIOLOGICAL MARKER; FAS LIGAND; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN;

ACUTE DISEASE; ADULT; ALLOTRANSPLANTATION; APOPTOSIS; ARTICLE; CHILD; DRUG EFFECT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; INFANT; INTESTINE MUCOSA; MALE; METABOLISM; PATHOLOGY; PHAGOCYTOSIS; PRESCHOOL CHILD; SMALL INTESTINE; T LYMPHOCYTE; TRANSPLANTATION;

ACUTE DISEASE; ANTIGENS, CD; APOPTOSIS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FAS LIGAND PROTEIN; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; PHAGOCYTOSIS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84872870688     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31826393fe     Document Type: Article

References (25)

1. Avitzur Y, Grant D. Intestine transplantation in children: update 2010. Pediatr Clin North Am. 2010;57:415-431. table of contents.
2. Goulet O, Sauvat F. Short bowel syndrome and intestinal transplantation in children. Curr Opin Clin Nutr Metab Care. 2006;9:304-313.
3. Kato T, Nishida S, Mittal N, et al. Intestinal transplantation at the University of Miami. Transplant Proc. 2002;34:868.
4. Pinna AD, Weppler D, Nery J, et al. Intestinal transplantation at the University of Miami-five years of experience. Transplant Proc. 2000;32:1226-1227.
5. Pirenne J, Hoffman I, Miserez M, et al. Selection criteria and outcome of patients referred to intestinal transplantation: a European center experience. Transplant Proc. 2006;38:1671-1672.
6. Reyes J. Intestinal transplantation for children with short bowel syndrome. Semin Pediatr Surg. 2001;10:99-104.
7. Tzakis AG, Tryphonopoulos P, Kato T, et al. Intestinal transplantation: advances in immunosuppression and surgical techniques. Transplant Proc. 2003;35:1925-1926.
8. Vanderhoof JA. Short bowel syndrome in children and small intestinal transplantation. Pediatr Clin North Am. 1996;43:533-550.
9. Bond GJ, Reyes JD. Intestinal transplantation for total/near-total aganglionosis and intestinal pseudo-obstruction. Semin Pediatr Surg. 2004;13:286-292.
10. Sharif K, Beath SV, Kelly DA, et al. New perspective for the management of near-total or total intestinal aganglionosis in infants. J Pediatr Surg. 2003;38:25-28; discussion 25-28.
11. Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplantation. Gastroenterology. 1996;110:1820-1834.
12. Ruiz P, Takahashi H, Delacruz V, et al. International grading scheme for acute cellular rejection in small-bowel transplantation: single-center experience. Transplant Proc. 2010;42:47-53.
13. Tsuruyama T, Fujimoto Y, Yonekawa Y, et al. Invariant natural killer T cells infiltrate intestinal allografts undergoing acute cellular rejection. Transpl Int. 2012;25:537-544.
14. White FV, Reyes J, Jaffe R, et al. Pathology of intestinal transplantation in children. Am J Surg Pathol. 1995;19:687-698.
15. Wu T, Abu-Elmagd K, Bond G, et al. A schema for histologic grading of small intestine allograft acute rejection. Transplantation. 2003;75:1241-1248.
16. Fujimoto Y, Uemoto S, Inomata Y, et al. Small bowel transplantation using grafts from living-related donors. Two case reports. Transpl Int. 2000;13(suppl 1):S179-S184.
17. Tachibana T, Onodera H, Tsuruyama T, et al. Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res. 2005;11:7322-7327.
18. Lin T, Brunner T, Tietz B, et al. Fas ligand-mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease. J Clin Invest. 1998;101:570-577.
19. MergerM, Viney JL, Borojevic R, et al. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine. Gut. 2002;51:155-163.
20. Stuber E, Buschenfeld A, von Freier A, et al. Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy. Gut. 1999;45:229-235.
21. Oshimi Y, Oda S, Honda Y, et al. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol. 1996;157:2909-2915.
22. Suda T, Hashimoto H, Tanaka M, et al. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med. 1997;186:2045-2050.
23. Miyagawa-Hayashino A, Tsuruyama T, Egawa H, et al. FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Am J Pathol. 2007;171:1499-1508.
24. Berrebi D, Sautet A, Flejou JF, et al. Ticlopidine induced colitis: a histopathological study including apoptosis. J Clin Pathol. 1998;51:280-283.
25. Wyllie AH, Morris RG, Smith AL, et al. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 1984;142:67-77.